Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed landmark results from the Phase 3 PANOVA-3 trial at ...

Actuate Therapeutics, Inc. (NASDAQ:ACTU) has announced breakthrough results from its Phase 2 trial of elraglusib combined ...

Shareholders of Black Spade Acquisition II Co (NASDAQ:BSII) have approved the proposed business combination with The ...

Grindr Inc. (NYSE:GRND) has officially launched its real-time discovery tool, Right Now, across all global markets.

Guardant Health, Inc. (NASDAQ:GH) and research collaborators have unveiled results from the largest study to date on ...

Wells Fargo began coverage on Bio-Techne Corporation (NASDAQ:TECH)’s stock with an “Overweight” rating and a price objective ...

Barclays analyst Julian Mitchell raised the firm’s price target on GE Vernova, Inc. (NYSE: GEV) to $500 from $427 on May 30, ...

Gordon Johnson, an analyst at GLJ Research, downgraded United States Steel Corporation (NYSE:X) from Buy to Sell on May 30, ...

Michael Baker from DA Davidson raised the price target on ULTA following its Q1 2025 earnings beat and guidance increase.

Xilio Therapeutics, Inc. (NASDAQ: XLO) announced promising updated Phase 2 results for its investigational therapy ...

BofA analyst Craig Bijou reiterated a Buy rating on Cooper Companies, Inc. (NASDAQ:COO), lowering the associated price target ...